The Effects of the Nanosphere Carrier for the Combined Carmustine-Busulfan Trastuzumab in Human Breast Cancer Tissue Culture

doi 10.36295/asro.2019.22073
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Africa Health Research Organization

Related search

The Use of Trastuzumab in New Zealand Women With Breast Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Trastuzumab-Containing Regimens for Metastatic Breast Cancer

Cochrane Database of Systematic Reviews
2014English

Cost Considerations in Determining the Affordability of Adjuvant Trastuzumab in Breast Cancer

South African Medical Journal
Medicine
2016English

Biologic and Immunologic Effects of Preoperative Trastuzumab for Ductal Carcinoma in Situ of the Breast

Cancer
Cancer ResearchOncology
2010English

Trastuzumab-Resistance and Breast Cancer

2011English

Utilization of Human Tissue in Breast Cancer Research

Breast Cancer Research
Cancer ResearchOncology
2000English

Trastuzumab in the Treatment of Metastatic Breast Cancer : Anticancer Therapy Versus Cardiotoxicity

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Trastuzumab-Dm1: A Review of the Novel Immuno-Conjugate for HER2- Overexpressing Breast Cancer

The Open Breast Cancer Journal
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy